Home NDC 42291-439-30 Emtricitabine and Tenofovir Disoproxil Fumarate
Product NDC 42291-439
Requested package NDC 42291-439-30
11-digit product format 422910439
Labeler code 42291
Product ID 42291-439_ec6b1bce-09cb-23a0-e053-2995a90ad50f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Emtricitabine and Tenofovir Disoproxil Fumarate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler AvKARE
Application ANDA209721
Marketing category ANDA
Marketing start 2021-03-30
Marketing end 0000-00-00
Substance EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active strength 200 mg/1; mg/1
Pharmacologic classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209721-001 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100MG;150MG TABLET / ORAL AB 2018-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209721-002 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133MG;200MG TABLET / ORAL AB 2018-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209721-003 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167MG;250MG TABLET / ORAL AB 2018-08-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209721-004 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200MG;300MG TABLET / ORAL AB 2018-08-22 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 150 observed states.
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42291-439 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLET, FILM COATED [AVKARE] 3 Legacy NDC 20240110_bec65789-2f4b-134d-e053-2a95a90ab597.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42291-439-30 42291043930 30 TABLET, FILM COATED in 1 BOTTLE (42291-439-30) 2021-03-30 0000-00-00 No No Current